Shiraishi T, Samloff I M, Taggart R T, Stemmermann G N
Research Service, Veterans Administration Medical Center, Sepulveda, California 91343.
Dig Dis Sci. 1988 Nov;33(11):1466-72. doi: 10.1007/BF01537004.
Slow-moving proteinase (SMP), pepsinogen I (PG I), and pepsinogen II (PG II) are aspartic proteinases normally found in gastric mucosa. Because of differences in their cellular origins, normal gastric epithelial cells can be phenotyped by immunohistochemical staining with a panel of antisera to each proteinase. In this study, we determined aspartic proteinase phenotypes of malignant cells in 74 cases of gastric cancer by immunohistochemical staining with rabbit antiserum to human SMP, PG I, and PG II. Of the 74 cancers, 20 were histologically of the diffuse type and 54 were of the intestinal (or mixed) type. Intestinal metaplasia was characterized by the presence of SMP (but not PG I or PG II) in absorptive epithelial cells. SMP was found in 40 (54%) of the cancers (vs 31% for PG II and only 5% for PG I) and in both the intestinal and diffuse types. Of the 40 SMP-positive cancers, 14 also expressed PG II. In the latter tumors, staining of adjacent sections revealed that some malignant cells expressed only SMP or only PG II, whereas others expressed both proteinases. Overall, 49 (66%) of the cancers contained cells with proteinase phenotypes characteristic of cells in nonmalignant gastric mucosa and 23% contained cells with proteinase phenotypes characteristic of more than one cell type. The results indicate that both intestinal- and diffuse-type gastric cancers often differentiate to cell types that produce aspartic proteinases and that about one fourth contain a heterogeneous population of malignant cells.
慢速移动蛋白酶(SMP)、胃蛋白酶原I(PG I)和胃蛋白酶原II(PG II)是通常存在于胃黏膜中的天冬氨酸蛋白酶。由于它们细胞来源的差异,正常胃上皮细胞可以通过用一组针对每种蛋白酶的抗血清进行免疫组织化学染色来进行表型分析。在本研究中,我们通过用兔抗人SMP、PG I和PG II的抗血清进行免疫组织化学染色,确定了74例胃癌中恶性细胞的天冬氨酸蛋白酶表型。在这74例癌症中,20例组织学类型为弥漫型,54例为肠型(或混合型)。肠化生的特征是吸收上皮细胞中存在SMP(但不存在PG I或PG II)。在40例(54%)癌症中发现了SMP(PG II为31%,PG I仅为5%),且在肠型和弥漫型中均有发现。在40例SMP阳性癌症中,14例也表达PG II。在后者的肿瘤中,相邻切片的染色显示,一些恶性细胞仅表达SMP或仅表达PG II,而另一些则同时表达这两种蛋白酶。总体而言,49例(66%)癌症含有具有非恶性胃黏膜细胞特征性蛋白酶表型的细胞,23%含有具有不止一种细胞类型特征性蛋白酶表型的细胞。结果表明,肠型和弥漫型胃癌通常会分化为产生天冬氨酸蛋白酶的细胞类型,并且约四分之一含有异质性的恶性细胞群体。